Investigational Site Number 1214

Nashville, Tennessee 37203

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Breast Neoplasms, Cancer, Non-small Cell Lung Cancer

Studies at this site

• Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen — Completed
• Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer — Completed
• Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors — Completed